Label and packaging requirements disclaimer. Although we try to keep this up to date as much as possible it is your responsibility to verify with your state on current changes. MSN Packaging is not legally responsible for lack of compliance based on information found on this page.

NEVADA

Nevada’s cannabis labeling and packaging guidelines include the following:

NAC 453A.500 Packaging: Generally. (NRS 453A.370):

• Any product containing marijuana must be packaged in child-resistant packaging in accordance with 16 C.F.R. § 1700 or the standards specified in subsection 2 or 3.
• Except as otherwise provided in subsection 3, marijuana-infused products in solid or liquid form must be packaged in plastic which is 4 millimeters or more in thickness and must be heat-sealed without an easy-open tab, dimple, corner, or flap so that it is difficult for a child to open and as a tamperproof measure.
• Marijuana-infused products in liquid form may be sealed using a metal crown cork-style bottle cap.
• Any container or packaging containing usable marijuana, edible marijuana products, or marijuana-infused products must protect the contents from contamination and must not impart any toxic or deleterious substance to the usable marijuana or marijuana product.

Labeling requirements for marijuana and related products for sale to medical marijuana dispensary (NRS 453A.370):

• A cultivation facility or facility for the production of edible marijuana products or marijuana-infused products shall label all marijuana, edible marijuana products, and marijuana-infused products before it sells the marijuana or marijuana products to a medical marijuana dispensary and shall securely affix to the package a label that includes, without limitation, in legible English:
  • (a) The name of the medical marijuana establishment and its medical marijuana establishment registration certificate number;
  • (b) The lot number;
  • (c) The date of harvest;
  • (d) The date of final testing;
  • (e) The date on which the product was packaged;
  • (f) The cannabinoid profile and potency levels and terpenoid profile as determined by the independent testing laboratory;
  • (g) If the product is perishable, the expiration date; and
  • (h) The quantity of marijuana being sold.

For more information, please refer to 

https://tax.nv.gov/uploadedFiles/taxnvgov/Content/Meetings/Marijuana-Overview-2-14-19.pdf

https://tax.nv.gov/uploadedFiles/taxnvgov/Content/Meetings/Packaging%20and%20Labeling%20of%20Marijuana%20and%20Marijuana%20Products%20and%20Advertising%20v.%203.pdf

 Chapter 453A – Medical Use of Marijuana.

NEW HAMPSHIRE

New Hampshire’s cannabis labeling and packaging guidelines require alternative treatment centers to provide a plan for safe and accurate packaging and labeling of cannabis, including the applicant’s plan for ensuring that all cannabis is free of contaminants.

For more information, please refer to New Hampshire House Bill 573.

NEW JERSEY

New Jersey’s cannabis labeling and packaging guidelines include the following:

• (b) The ATC–plant cultivation shall place a legible, firmly affixed label containing the information specified in (c) below on each package of medical marijuana it dispenses to an ATC–dispensary and shall not dispense medical marijuana if the package does not bear the label.
• (c) The label required pursuant to (b) above shall contain the following:
  • The name and address of the alternative treatment center–plant cultivation that produced the medical marijuana;
  • The quantity of the medical marijuana contained within the package;
  • The date that the ATC–plant cultivation packaged the content;
  • A sequential serial number, lot number, and bar code to identify lot associated with manufacturing and processing;
  • The cannabinoid profile of the medical marijuana contained within the package, including THC level not to exceed 10 percent;
  • Whether the medical marijuana is of the low, medium, or high strength strain;
  • A statement that the product is for medical use by a qualifying patient and not for resale; and
  • A list of any other ingredients besides medical marijuana contained within the package.
• (d) Labeling shall be clear and truthful in all respects and shall not be false or misleading in any particular.
• A label containing any statements about the product other than those specified in this chapter shall contain the following statement prominently displayed, and in boldface type: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

For more information, please refer to New Jersey Register Draft Regulations for the Medicinal Marijuana Program.

https://www.nj.gov/cannabis/medicinalcannabis/medicinal/

NEW MEXICO

New Mexico’s cannabis labeling and packaging guidelines include the following:

• Packaging and labeling: a manufacturer applicant shall submit a description and sample of the opaque, child-resistant packaging of the concentrate or cannabis-derived product that the manufacturer shall utilize, including a label that shall contain:
  • (1) the name of the entity that produced the cannabis and the name of the manufacturer;
  • (2) a batch number or code;
  • (3) a production date or expiration date, including a “use by” or “freeze by” date for products capable of supporting the growth of infectious, toxigenic, or spoilage microorganisms;
  • (4) a description of the number of units of usable cannabis contained within the product;
  • (5) instructions for use;
  • (6) warnings for use;
  • (7) instructions for appropriate storage;
  • (8) approved laboratory analysis, including the results of strength and composition within ten percent (10%) of numbers shown on the package;
  • (9) the name of the strain, product facts, or a nutrition fact panel, and a statement that the product is for medical use by qualified patients, to be kept away from children, and not for resale; and
  • (10) the name of the department-approved testing facility or facilities used for ingredient testing, and the type(s) of testing conducted.

For more information, please refer to Title 7, Chapter 34, Part 4 – Licensing Requirements for Producers, Couriers, Manufacturers and Laboratories.

NEW YORK

NEW YORK 2022 Packaging updates 

• (g) Approved medical marihuana products shall be limited to the following forms and routes of administration:(1) liquid or oil preparations for metered or omucosal or sublingual administration or administration per tube;(2) metered liquid or oil preparations for vaporization;(3) capsules for oral administration; or(4) any additional form and route of administration approved by the commissioner. Smoking is not an approved route of administration.

(5) approved medical marihuana products may not be incorporated into edible food products by the registered organization, unless approved by the commissioner.

(h) The registered organization shall package the final form of the approved medical marihuana product at the manufacturing site. The original seal shall not be broken except for quality testing at an approved laboratory, for adverse event investigations, by the department, or by the certified patient or designated caregiver.

(i) The registered organization shall package the approved medical marihuana product such that it is child-resistant, tamper-proof/tamper-evident, light-resistant, and in a resealable package that minimizes oxygen exposure.

(j) The registered organization shall identify each lot of approved medical marihuana product with a lot unique identifier.

(k) Each approved medical marihuana product shall be affixed with a product label. Medical marihuana product labels shall be approved by the department prior to use. Each product label shall be applied at the manufacturing facility, be easily readable, firmly affixed and include:

(1) the name, address and registration number of the registered organization;

(2) the medical marihuana product form and brand designation;

(3) the single dose THC and CBD content for the product set forth in milligrams (mg);

(4) the medical marihuana product lot unique identifier (lot number or bar code);

(5) the quantity included in the package;

(6) the date packaged;

(7) the date of expiration of the product;

(8) the proper storage conditions;

(9) language stating:

(i) “Medical marihuana products must be kept in the original container in which they were dispensed and removed from the original container only when ready for use by the certified patient”;

(ii) “Keep secured at all times”;

(iii) “May not be resold or transferred to another person”;

(iv) “This product might impair the ability to drive”;

(v) “KEEP THIS PRODUCT AWAY FROM CHILDREN (unless medical marihuana product is being given to the child under a practitioner’s care”); and
(vi) “This product is for medicinal use only. Women should not consume during pregnancy or while breastfeeding except on the advice of the certifying practitioner, and in the case of breastfeeding mothers, including the infant’s pediatrician.”

(l) For each lot of medical marihuana product produced, the registered organization shall submit a predetermined number of final medical marihuana products (e.g., sealed vials or capsules; with the number of samples submitted, based on statistical analysis, determined to be representative of the lot) to an independent laboratory/laboratories approved by the department. The laboratory verifying the cannabinoid content shall be approved for the analysis of medical marihuana product by the department in accordance with section five hundred two of the public health law and subpart 55-2 of this title. Such laboratory, or approved laboratories cumulatively, shall certify the medical marihuana product lot as passing all contaminant testing and verify that the content is consistent with the brand prior to the medical marihuana product being released from the manufacturer to any dispensing facility.

(1) Any lot not meeting the minimum standards or specifications for safety shall be rejected and destroyed by the registered organization in accordance with the registered organization’s approved operating plan.

(2) Any lot not meeting the minimum standards or specifications for brand consistency shall be rejected and destroyed by the registered organization in accordance with the registered organization’s approved operating plan.

(3) The registered organization shall keep and maintain records documenting submission of medical marihuana products to approved laboratories as required herein, and the results of the laboratory testing. The registered organization shall provide the department with such records upon request.

(m) The registered organization shall demonstrate the stability of each approved medical marihuana product produced (each brand in each form) by testing at an approved laboratory in accordance with section 1004.14 of this title:

(1) the stability and expiration date of the final distributed medical marijuana product shall be validated and shall be stable for a minimum of 60 days under the specified storage conditions (light, temperature and humidity) when opened;

(2) shelf-life of unopened medical marihuana products (e.g., packages or vials) shall be validated by ongoing stability testing according to a schedule determined by the department and an expiration date for unopened products shall be determined through the stability testing;

(3) specifications regarding storage conditions must address storage at the manufacturing facility once the package is sealed, during transport, at the dispensing facility, in the patient’s home and for samples retained for future testing.

(n) No synthetic marihuana additives shall be used in the production of any medical marihuana product.

For more information, please refer to the New York Medical Marijuana Program Regulations.

NORTH DAKOTA 

Updated March 2023

General Authority: NDCC 19-24.1-36 Law Implemented: 33-44-01-25.

Usable marijuana packaging. A manufacturing facility shall package all usable marijuana intended for distribution according to the following standards:

1. Usable marijuana containers must be:

           a. Plain.

           b. Tamper-evident.

           c. Child-resistant.

2. Usable marijuana must be packaged to minimize its appeal to children.

33-44-01-26. Manufacturing facility labeling. 1. A manufacturing facility shall label all usable marijuana in accordance with the following before their sale or transfer to a dispensary: a. A container holding dried leaves and flowers must include the following information:

For more information, please refer. https://www.ndlegis.gov/information/acdata/pdf/33-44-01.pdf

North Dakota Medical Marijuana Program (nd.gov)

http://www.ndhealth.gov/mm/pdf/law,_rules_and_federal_guidance/proposed%20medical%20marijuana%20administrative%20rules.pdf

 NORTH CAROLINA

Information for Producers | Agricultural Marketing Service (usda.gov)

OHIO

•  In Ohio, medical marijuana is legal while recreational marijuana remains illegal.

• Persons 18 and older may purchase medical marijuana from a licensed medical marijuana dispensary. However, smoking marijuana in public remains illegal.

• It is legal to possess a 90-day supply of medical marijuana. It is a felony to possess over 200 grams of marijuana.

• It is illegal to grow weed both for medical or recreational use.

• There are penalties for the possession, cultivation, sales, trafficking, and distribution of weed in Ohio.

 At this time because Ohio is only Medical the Packaging regulations are as most states, based on the total grams in Ea container with limited Child Resistant requirements. 

For more information on Ohio's legal cannabis Ohio Marijuana Laws | OhioStateCannabis.org

OKLAHOMA

SUBCHAPTER 7. PACKAGING AND LABELING

310:681-7-1. Labeling The following general label and packaging requirements, prohibitions and exceptions apply:

SUBCHAPTER 7. PACKAGING AND LABELING 310:681-7-1. Labeling The following general label and packaging requirements, prohibitions and exceptions apply:

(1) Labels and packages may not be attractive to minors.

(2) Packaging must contain a label that reads: "Keep out of reach of children."

(3) All medical marijuana and medical marijuana products must be packaged in child resistant packages.

(4) Label must contain a warning that states "Women should not use marijuana or medical marijuana products during pregnancy because of the risk of birth defects." 310:681-7-2. Prohibited products (a) No commercial establishment shall manufacture, process, or offer for sale or consumption any medical marijuana product intended to be attractive to children or minors. (b) No commercial establishment, other than a licensed dispensary, shall offer for sale any marijuana seedlings or mature plants. No mature plants are authorized in the possession of either a commercial establishment licensee or patient license holder until 60 days after August 27, 2018. No seedlings are authorized in the possession of a commercial establishment license holder until 7 days after August 27, 2018.

 (e) Labeling and Packaging. Labels and packages for food containing marijuana shall comply with all applicable requirements in existing Oklahoma law, rules, and regulations, and any laws incorporated therein by reference, to the extent they do not conflict with 63 O.S. § 420A.

(1) Title 21, part 101 of the Code of Federal Regulations ("CFR"), as of August 22, 2018, is hereby incorporated by reference into this Section to the extent it is applicable and does not conflict with 63 O.S. § 420A et seq.

(2) Existing requirements for principal display panels or information panels include: (A) Name and address of the business; (B) Name of the food; (C) Net quantity or weight of contents; (D) Ingredients list; (E) Food allergen information; and (F) Nutrition labeling, if required under 21 CFR § 101.9.

(3) In addition, principal display panels or information panels must contain: (A) List of cannabis ingredients; (B) The batch of marijuana; (C) The strain of marijuana (optional); (D) THC dosage in milligrams per unit; and (E) The lot code.

(4) Nutrient content, health, qualified health and structure/function claims must comply with the Food and Drug Administration ("FDA") Food Labeling Guide.

(5) Packaging must contain the statement, "For accidental ingestion call 1-800-222-1222."

(6) All packages and individually-packaged product units, including but not limited to those from bulk packaging, must contain the Oklahoma uniform symbol in clear and plain sight. The Oklahoma uniform symbol must be printed at least one-half inch by one-half inch in size in color.

(7) In order to comply with OAC 310:681-7-1(4) and this Section, a label must contain a warning that states, "Women should not use marijuana or medical marijuana products during pregnancy because of the risk of birth defects or while breastfeeding." (f) Recommended HACCP. A Hazard Analysis and Critical Control Plan 

For more information on Oklahoma state requirements  Updated 2019

OREGON

Oregon’s cannabis labeling and packaging guidelines fall under 333-008-1225 Packaging and include the following:

• (1) For purposes of this rule:
  • (a) “Child-resistant safety packaging” means:
    • (A) Containers designed and constructed to be significantly difficult for children under five years of age to open and not difficult for adults to use properly;
    • (B) Opaque so that the product cannot be seen from outside the packaging;
    • (C) Closable for any product intended for more than a single use or containing multiple servings; and
    • (D) Labeled in accordance with OAR 333-008-1220.
  • (b) “Container” means a sealed, hard, or soft-bodied receptacle in which a tetrahydrocannabinol infused product is placed prior to being transferred to a patient or caregiver.
  • c) “Packaged in a manner not attractive to minors” means the tetrahydrocannabinol-infused product is not in a container that is brightly colored, depicts cartoons or images other than the logo of the facility, unless the logo of the facility depicts cartoons, in which case only the name of the facility is permitted.
• (2) A registered facility may not transfer any tetrahydrocannabinol-infused product that is meant to be swallowed or inhaled, unless the product is:
  • (a) In child-resistant safety packaging; and
  • (b) Packaged in a manner that is not attractive to minors.

Label Check list for Recreational Marijuana Program: 

http://www.oregon.gov/olcc/marijuana/Documents/Packaging_Labeling/ChecklistandGeneric.pdf

For more information, please refer to the Final Rules for the Medical Marijuana Dispensary Program.

Pre Roll Infused labeling updated March 2023

https://www.oregon.gov/olcc/marijuana/Documents/Bulletins/CE2023-01-Pre-Roll-Testing-Guidance.pdf

 PENNSYLVANIA

§ 1151.34. Packaging and labeling of medical marijuana products.

 (a)  A grower/processor shall package and label at its facility each form of medical marijuana products prepared for sale. The original seal of a package may not be broken, except for quality control testing at an approved laboratory, for adverse loss investigations conducted by the Department or by a dispensary that purchased the medical marijuana products.

 (b)  A grower/processor shall package the medical marijuana products in a package that minimizes exposure to oxygen and that is:

   (1)  Child-resistant.

   (2)  Tamper-proof or tamper-evident.

   (3)  Light-resistant or opaque, or both.

   (4)  Resealable.

 (c)  A grower/processor shall identify each process lot of medical marijuana with a unique identifier.

 (d)  A grower/processor shall obtain the prior written approval of the Department of the content of any label to be affixed to a medical marijuana product package. Each label must meet the following requirements:

   (1)  Be easily readable.

   (2)  Made of weather-resistant and tamper-resistant materials.

   (3)  Be conspicuously placed on the package.

   (4)  Include the name, address and permit number of the grower/processor.

   (5)  List the form, quantity and weight of medical marijuana included in the package.

   (6)  List the number of individual doses contained within the package, and the species and percentage of THC and CBD.

   (7)  Contain an identifier that is unique to a particular harvest batch of medical marijuana, including the number assigned to each harvest lot or process lot in the harvest batch.

   (8)  Include the date the medical marijuana product was packaged.

   (9)  State the employee identification number of the employee preparing the package and packaging the medical marijuana product.

   (10)  State the employee identification number of the employee shipping the package, if different than the employee described in paragraph (9).

   (11)  Contain the name and address of the dispensary to which the package is to be sold.

   (12)  List the date of expiration of the medical marijuana product.

   (13)  Include instructions for proper storage of the medical marijuana product in the package.

   (14)  Contain the following warning stating:

 This product is for medicinal use only. Women should not consume during pregnancy or while breastfeeding except on the advice of the practitioner who issued the certification and, in the case of breastfeeding, the infant’s pediatrician. This product might impair the ability to drive or operate heavy machinery. Keep out of reach of children.

   (15)  Contain a warning that the medical marijuana product must be kept in the original container in which it was dispensed.

   (16)  Contain a warning that unauthorized use is unlawful and will subject the purchaser to criminal penalties.

 (e)  Labeling by a grower/processor of any medical marijuana product may not bear:

   (1)  Any resemblance to the trademarked, characteristic or product-specialized packaging of any commercially available food or beverage product.

   (2)  Any statement, artwork or design that could reasonably lead an individual to believe that the package contains anything other than medical marijuana.

   (3)  Any seal, flag, crest, coat of arms or other insignia that could reasonably mislead an individual to believe that the product has been endorsed, manufactured or approved for use by any state, county or municipality or any agency thereof.

https://www.health.pa.gov/topics/programs/Medical%20Marijuana/Pages/Medical%20Marijuana.aspx

RHODE ISLAND

Rhode Island’s cannabis labeling and packaging guidelines include the following:

• Product Packaging and Labeling Requirements
• 1. Authority and Applicability
•  a. These product packaging and labeling requirements for compassion centers are promulgated pursuant to R.I. Gen. Laws § 21-28.6-12(f)(11). These requirements were developed jointly with DOH.
• b. Compassion centers shall have ninety (90) calendar days from the effective date of these regulations to comply with these requirements.
• c. Any container or packaging containing usable marijuana or marijuana product, including both retail-retail ready packaging and product otherwise packaged for the purpose of storage and/or authorized transport, must:
•                              (1) Protect the product from contamination.
•                              (2) Not impart any toxic or deleterious substance to the usable marijuana or marijuana product.
•                              (3) Contain the Inventory tracking ID number assigned by the Medical Marijuana Program Tracking System or, if prior to the Medical Marijuana Program Tracking System’s implementation, an inventory tracking ID number generated from an alternative inventory tracking system approved by DBR.
•                            (4) Be labeled with the quantity of the product.
• d. The remainder of these product packaging and labeling requirements only apply to retail-ready product packaging and labeling.
• e. Compliance with these product packaging and labeling requirements shall include the requirement that retail-ready product complies with the DOH Testing Regulation, once adopted.
• f. While a compassion center is permitted to purchase medical marijuana and medical marijuana products from a Rhode Island licensed cultivator pursuant to a written contract/purchase order, including final products that have already been packaged, labeled, and/or tested, the compassion center is responsible for ensuring the integrity of the product, compliance of the packaging and labeling, including particularly that the products have the correct composition and profiles that are advertised/indicated in the label.

• 2. Packaging and labeling shall not:

• a. Make any false or misleading statements including particularly any statements regarding health or physical benefits to the consumer and the composition and profiles that are advertised/indicated in the label.
• b. Resemble the trademarked, characteristic or product-specialized packaging of any commercially available snack, baked good, or beverage.
• c. Contain any statement, artwork, or design that could reasonably mislead any reasonably prudent person to believe that the package contains anything other than medical marijuana or marijuana product.
• d. Contain any seal, flag, crest, coat of arms, or other insignia that could reasonably mislead any reasonably prudent person to believe that the product has been endorsed or manufactured by the State of Rhode Island or any agency thereof or municipality within.
• 3. Packaging for medical marijuana and marijuana products sold at retail shall be opaque, light-resistant, and tamper-evident.
• 4. Packaging and labeling shall not be designed such that it would be attractive to children. This requires the packing and labeling be in black and white only, have no animal characters, and does not contain the word “candy.”
• 5. Medical marijuana and marijuana products sold at retail must be packaged in manner that is “child-resistant,” which for purposes of these Regulations shall mean that the packaging is designed and constructed to be significantly difficult for children under five years of age to open. Approved methods include but are not limited to: a. Solid or liquid marijuana products may be packaged in plastic four mil or greater in thickness and be heat sealed with no easy-open tab, dimple, corner, or flap. b. Liquid marijuana products may also be packaged in a bottle and sealed using a metal crown cork style bottle cap or other similar sealing method pre-approved by DBR.
• 6. For solid edible marijuana products with more than one serving size in the outer package, each serving must be packaged individually and placed in a child-resistant outer package.
• 7. For liquid edible marijuana products with more than one serving in the package, a measuring cap or dropper must be included in the package with the product.
• 8. All medical marijuana and marijuana products when sold at retail must include a label affixed to the package containing the following information, prominently displayed and in a clear and legible English language font: a. The business or trade name of the selling compassion center. b. Inventory tracking ID number assigned by the Medical Marijuana Program Tracking System or, if prior to the Medical Marijuana Program Tracking System’s implementation, an inventory tracking ID number generated from an alternative inventory tracking system approved by DBR. c. Date of final packaging, and, if applicable, the recommended expiration or “use by” date. d. Total weight in ounces and grams or volume as appropriate. Weight and volume must be determined using accurately calibrated equipment which equipment must also comply with any other applicable state laws. e. Total estimated amount of THC and total estimated amount of CBD. f. For edible marijuana products, a list of all ingredients used. g. A statement that discloses all pesticides applied to the marijuana plants and growing medium during production and processing. h. If solvents were used, statement that discloses the type of extraction method, including any solvents, gases, or other chemicals or compounds used to produce or that are added to the extract. i. Any applicable instructions for use and safe storage.
• 9. All medical marijuana and marijuana products when sold at retail must include a label affixed to the package containing the following warnings, prominently displayed and in a clear and legible English language font. For products other than edibles and topical applications, these warnings may be on an insert provided with the packaging.
•                            a. “Warning: Marijuana has intoxicating effects and may be habit forming and addictive. The intoxicating effects of marijuana may be delayed by up to two hours.”
•                            b. “Warning: Do not operate a vehicle or machinery under its influence.”
•                            c. “Warning: There may be health risks associated with consumption of marijuana.”
•                            d. “Warning: For use only by adults twenty-one and older. Keep out of reach of children.”
•                            e. “Warning: Marijuana should not be used by women that are pregnant or breast feeding.”
•                           f. “Warning: Do not take this product across state lines.”
•                           g. “Warning: For medical use by a registered patient only. Not for resale.”
•                           h. “Warning: This product is not certified to be free of contaminants.”   
•                           i. For product to be smoked, “Warning: Smoking is hazardous to your health.”
•                           j. If applicable, a warning regarding use or contact with any nuts or other known allergens as defined in the federal Food Allergen Labeling and Consumer Protection Act of 2004, as administered by the federal Food and Drug Administration. 10. Notwithstanding any of the product labeling requirements set forth in § 1.4(H) of this Part, application may be made to DBR for approval to affix a two inch (2”) by two inch (2”) logo or graphic, which may be colored, for the purpose of identifying the compassion center selling and/or the cultivator producing the product.

For more information, please refer to the Rules and Regulations Related to the Medical Marijuana Program.

Texas

The provisions of this §300.402 adopted to be effective August 2, 2020, 45 TexReg 5195

(a) All consumable hemp products marketed as containing more than trace amounts of cannabinoids must, in addition to the requirements of §300.102 of this chapter (relating to Applicability of Other Rules and Regulations), be labeled in the manner provided by this section with the following information:

   (1) lot number;

   (2) lot date;

   (3) product name;

   (4) the name of the product's manufacturer;

   (5) telephone number and email address of manufacturer; and

   (6) a Certificate of Analysis that the delta-9 tetrahydrocannabinol content concentration level on a dry weight basis, that, when reported with the accredited laboratory's measurement of uncertainty, produces a distribution or range that includes a result of 0.3 percent or less.

 (b) The label required by this section must appear on each product intended for individual retail sale.

 (c) The label required by this section may be in the form of:

  (1) a uniform resource locator (URL) for the manufacturer's Internet website that provides or links to the information required by this section; and

   (2) a QR code or other bar code that may be scanned and that leads to the information required on the label.

Here is the e-mail address for questions regarding the Retail of Hemp/CBD products: DSHSHempProgram@dshs.texas.gov

 Here is the Retail/Manufacturing information on Hemp/CBD for the Texas Hemp program: https://www.dshs.texas.gov/consumerprotection/hemp-program/default.aspx.  

Here is the information for the hemp growing with Texas Department of Agriculture (https://texasagriculture.gov/RegulatoryPrograms/Hemp.aspx).

 Recreational Laws on Marijuana See More info

Texas Law Library : CBD & Industrial Hemp - Cannabis and the Law - Guides at Texas State Law Library

VERMONT

Vermont’s cannabis labeling and packaging guidelines include the following:

• A registered dispensary shall package all marijuana dispensed in an envelope or other container used and intended for sale.
• A label shall be affixed on the packaging of all marijuana that is dispensed. The label shall identify the particular strain of marijuana and the weight of marijuana contained within the package in gram or ounce units. Marijuana strains shall reflect the properties of the plant.
• Additionally, the label shall contain a statement to the effect that the State of Vermont does not attest to the medicinal value of cannabis, a statement that this product is not for resale, and clearly identify “marijuana” is contained within the packaging.
• The dispensary shall verify the amount of all marijuana dispensed.
• Documentation shall be maintained containing at a minimum the name and registry identification number of the registered dispensary cardholders verifying the amount of marijuana and any errors identified.

General Rules To fully understand these rules, please refer to the definitions section below where key words are defined. Each defined word in these rules has an asterisk after it.

1. In general, packaging that is intended for consumer purchase at a retail location shall be reusable* and shall not be plastic*. Examples of reusable, non-plastic packaging materials include glass, tin, cardboard, and bamboo. a. This rule does not apply to packaging used solely for the transfer of cannabis or cannabis products between licensees.

2. Consumer packaging for cannabis* must be child-deterrent*.

3. Consumer packaging for cannabis products* must be opaque and child-resistant*.

4. Packages and containers that hold cannabis and cannabis products must protect those items from contamination and must not expose the cannabis and cannabis products to any toxic or harmful substance.

Definitions

1. “Cannabis” means all parts of the plant Cannabis sativa L., including the seeds, resin extracted from any part of the plant, and any compound, manufacture, salt, derivative, or preparation of the plant, its seeds, or resin.

2. “Cannabis Product” means concentrated cannabis and a product that is composed of cannabis and other ingredients and is intended for use or consumption, including an edible product, ointment, tincture, and vaporizer cartridges containing cannabis oil.

3. “Child-deterrent packaging” means tear-resistant packaging that can be sealed in a manner that would deter children under five years of age from easily accessing the contents of the package within a reasonable time and not difficult for adults to use properly.

4. “Child-resistant packaging” means packaging that is designed or constructed to be significantly difficult for children under five years of age to open or obtain a toxic or harmful amount of the substance in the container within a reasonable time and not difficult for normal adults to use properly, but does not mean packaging that all children under five years of age cannot open or obtain a toxic or harmful amount of the substance in the container within a reasonable time.

5. “Plastic” means a synthetic material made from linking monomers through a chemical reaction to create a polymer chain that can be molded or extruded at high heat into various solid forms that retain their defined shapes during their life cycle and after disposal, including material 3 derived from either petroleum or a biologically based polymer, such as corn or other plant sources.

6. “Reusable” means packaging that is capable of repeated recovery, inspection, sanitation, repair if necessary, and reissue into the supply chain for repeated use.

For more information, please refer to the Guidance on Packaging (vermont.gov)

WASHINGTON

Washington’s cannabis labeling and packaging guidelines include the following:

• (10) Labels must comply with the version of NIST Handbook 130, Uniform Packaging and Labeling Regulation adopted in chapter 16-662
• (11) All usable marijuana when sold at retail must include accompanying material that contains the following warnings that state:
  • (a) “Warning: This product has intoxicating effects and may be habit forming. Smoking is hazardous to your health”;
  • (b) “There may be health risks associated with consumption of this product”;
  • (c) “Should not be used by women that are pregnant or breast feeding”;
  • (d) “For use only by adults twenty-one and older. Keep out of reach of children”;
  • (e) “Marijuana can impair concentration, coordination, and judgment. Do not operate a vehicle or machinery under the influence of this drug”;
  • (f) Statement that discloses all pesticides applied to the marijuana plants and growing medium during production and processing.
• (12) All marijuana concentrates and marijuana-infused products sold at retail must include accompanying material that contains the following warnings that state:
  • (a) “There may be health risks associated with consumption of this product”;
  • (b) “This product is infused with marijuana or active compounds of marijuana”;
  • (c) “Should not be used by women that are pregnant or breast feeding”;
  • (d) “For use only by adults twenty-one and older. Keep out of reach of children”;
  • (e) “Products containing marijuana can impair concentration, coordination, and judgment. Do not operate a vehicle or machinery under the influence of this drug”;
  • (f) “Caution: When eaten or swallowed, the intoxicating effects of this drug may be delayed by two or more hours”;
  • (g) Statement that discloses all pesticides applied to the marijuana plants and growing medium during production of the base marijuana used to create the extract added to the infused product; and
  • (h) Statement that discloses the type of extraction method, including any solvents, gases, or other chemicals or compounds used to produce or that are added to the extract.
• (13) Labels affixed to the container or package containing usable marijuana sold at retail must include:
  • (a) The business or trade name and Washington state unified business identifier number of the licensees that produced, processed, and sold the usable marijuana. The marijuana retail licensee trade name and Washington state unified business identifier number may be in the form of a sticker placed on the label;
  • (b) Inventory ID number assigned by the liquor control board’s traceability system. This must be the same number that appears on the transport manifest;
  • (c) Concentration of THC (total THC and activated THC-A) and CBD;
  • (d) Net weight in ounces and grams or volume as appropriate;
  • (e) Warnings that state: “This product has intoxicating effects and may be habit forming”;
  • (f) Statement that “This product may be unlawful outside of Washington state”;
  • (g) Date of harvest; and
  • (h) The board may create a logo that must be placed on all usable marijuana and marijuana-infused products.
• (15) Labels affixed to the container or package containing marijuana-infused products sold at retail must include:
  • (a) The business or trade name and Washington state unified business identifier number of the licensees that produced, processed, and sold the marijuana. The marijuana retail licensee trade name and Washington state unified business identifier number may be in the form of a sticker placed on the label;
  • (b) Inventory ID number assigned by the liquor control board’s traceability system. This must be the same number that appears on the transport manifest;
  • (c) Date manufactured;
  • (d) Best by date;
  • (e) Products meant to be eaten or swallowed, recommended serving size and the number of servings contained within the unit, including total milligrams of active tetrahydrocannabinol (THC), or Delta 9;
  • (f) Net weight in ounces and grams, or volume as appropriate;
  • (g) List of all ingredients and major food allergens as defined in the Food Allergen Labeling and Consumer Protection Act of 2004;
  • (h) “Caution: When eaten or swallowed, the intoxicating effects of this drug may be delayed by two or more hours.”;
  • (i) If a marijuana extract was added to the product, disclosure of the type of extraction process and any solvent, gas, or other chemical used in the extraction process, or any other compound added to the extract;
  • (j) Warnings that state: “This product has intoxicating effects and may be habit forming”;
  • (k) Statement that “This product may be unlawful outside of Washington state”;
  • (l) The board may create a logo that must be placed on all usable marijuana and marijuana-infused products.
• (17) Labels affixed to the container or package containing marijuana concentrates sold at retail must include:
  • (a) The business or trade name and Washington state unified business identifier number of the licensees that produced, processed, and sold the marijuana concentrate. The marijuana retail licensee trade name and Washington state unified business identifier may be in the form of a sticker placed on the label;
  • (b) Inventory ID number assigned by the liquor control board traceability system. This must be the same number that appears on the transportation manifest;
  • (c) Date manufactured;
  • (d) Best by date;
  • (e) Net weight in ounces and grams, or volume as appropriate;
  • (f) If a marijuana extract was added to the product, disclosure of the type of extraction process and any solvent, gas, or other chemical used in the extraction process, or any other compound added to the extract;
  • (g) Concentration of THC (total Delta 9 and Delta 9 THC-A) and CBD;
  • (h) Warnings that state “This product has intoxicating effects and may be habit forming”;
  • (i) Statement that “This product may be unlawful outside Washington state”; and
  • (j) The board may create a logo that must be placed on all usable marijuana and marijuana-infused products.

For more information, please refer to the Washington Administrative Code 314-55-105 for Packaging and Labeling Requirements.

Marijuana-infused product, label, and package approval process:
A marijuana processor licensee must obtain approval from the Liquor and Cannabis Board for all marijuana-infused products, labeling, and packaging prior to offering these items for sale to a marijuana retailer. The marijuana processor licensee must submit a photo of the product, labeling, and packaging to the liquor control board for approval. The photo(s) provided shall be of sufficient clarity to illustrate the requirements outlined below.

A marijuana processor producing a marijuana-infused solid or liquid product meant to be ingested orally in a processing facility as required in WAC 314-55-015(10) must pass a processing facility inspection prior to the request for approval of a marijuana-infused product.

• The marijuana processor licensee must send an email requesting approval with the required information torules@lcb.wa.gov.

Washington DC

Section 5607, LABELING AND PACKAGING OF MEDICAL MARIJUANA, is amended as follows:

 Subsection 5607.1(a) is amended to read as follows:

 5607.1             No medical marijuana shall be dispensed or distributed to a qualifying patient or caregiver unless the container in which it is distributed bears a legible label, firmly affixed, stating:

             (a)      The name of the cultivation center where the medical marijuana was produced and the manufacture date;

Subsection 5607.1(i) is amended to read as follows:

 5607.1  (i)         A statement that the product is for medical use, not for resale or transfer to another person, containing the following language: “Contains Marijuana. Keep out of the reach of children.”

Subsection 5607.10 is redesignated as Subsection 5607.17.

 New Subsections 5607.10 - 5607.16 are added to read as follows:

 5607.10           A cultivation center or dispensary shall not use the word(s) “candy” or “candies” on the product, packaging, or labeling of any medical marijuana product.

5607.11           A cultivation center or dispensary shall not place any content, image, or labeling that specifically targets individuals under the age of twenty-one (21), including but not limited to, cartoon characters or similar images, on the product, packaging, or a container holding medical marijuana.

5607.12           A cultivation center that produces edible marijuana products or marijuana-infused products shall ensure that all edible marijuana products or marijuana-infused products offered for sale:

•  Are labeled clearly and unambiguously as medical marijuana;
•  Are not presented in packaging or with labeling that is appealing to children; and
•  Have packaging designed or constructed to be significantly difficult for children under five (5) years of age to open, but not normally difficult for adults to use properly.

 5607.13           A cultivation center or dispensary shall not use or allow the use of any content, image, or labeling on a medical marijuana product that is offered for sale if the container does not precisely and clearly indicate the nature of the contents or that in any way may deceive a customer as to the nature, composition, quantity, age, or quality of the product.

 5607.14           Packaging of edible medical marijuana products or medical marijuana-infused products shall not bear any:

(a)   Resemblance to the trademarked, characteristic or product-specialized packaging of any commercially available candy, snack, baked good or beverage 

5607.15           The Director may prohibit a cultivation center or dispensary from selling any medical marijuana product upon a finding by the Director that the product is deceptively labeled or branded in a manner which is misleading about its content or that contains injurious or adulterated ingredients.

5607.16           In addition to the other labeling requirements of this section, all edible marijuana products, and marijuana-infused products shall be labeled in accordance with 16 C.F.R. Part 1700 (2016), Poison prevention packaging; 21 C.F.R. Part 101 (2016), Food Labeling, as specified in Section 1102 of the District Food Code Regulations (Title 25-A DCMR).

 http://www.dcregs.dc.gov/Gateway/NoticeHome.aspx?NoticeID=6275723